Akt-dependent nuclear localization of Y-box-binding protein 1 in acquisition of malignant characteristics by human ovarian cancer cells

Oncogene

Volumn 26, Issue 19, 2007, Pages 2736-2746

  Basaki, Y ^a,b   Hosoi, F ^a,b,c   Oda, Y ^b   Fotovati, A ^c   Maruyama, Y ^c   Oie, S ^a,b   Ono, M ^a,b,c   Izumi, H ^d   Kohno, K ^d   Sakai, K ^e   Shimoyama, T ^e   Nishio, K ^e   Kuwano, M ^a,c  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c KURUME UNIVERSITY   (Japan)

^d UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^e NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Akt; Microarray; Ovarian carcinoma; Y box binding protein 1

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CALCIUM BINDING PROTEIN; CHEMOKINE RECEPTOR CXCR4; CYCLIN B; MULTIDRUG RESISTANCE PROTEIN 1; OCTADECYLCARBONATE; OLIGONUCLEOTIDE; PHOSPHOLIPASE C; PROTEIN KINASE B; PROTEIN KINASE B INHIBITOR; PROTEIN S 100; SMALL INTERFERING RNA; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG; UVOMORULIN; Y BOX BINDING PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA MICROARRAY; ENZYME ACTIVATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; ONCOGENE C MYB; OVARY CANCER; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CELL NUCLEUS; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NUCLEAR PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIAN NEOPLASMS; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CXCR4; RNA, SMALL INTERFERING; TRANSCRIPTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA;

EID: 34247506814     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210084     Document Type: Article

References (42)

1. Altomare DA, Wang HQ, Skele KL, De Rienzo A, Klein-Szanto AJ, Godwin AK et al. (2004). AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth. Oncogene 23: 5853-5857.
2. Asakuno K, Kohno K, Uchiumi T, Kubo T, Sato S, Isono M et al. (1994). Involvement of a DNA binding protein, MDR-NF1/YB-1, in human MDR1 gene expression by actinomycin D. Biochem Biophys Res Commun 199: 1428-1435.
3. Ashizuka M, Fukuda T, Nakamura T, Shirasuna K, Iwai K, Izumi H et al. (2002). Novel translational control through an iron-responsive element by interaction of multifunctional protein YB-1 and IRP2. Mol Cell Biol 22: 6375-6383.
4. Bargou RC, Jurchott K, Wagener C, Bergmann S, Metzner S, Bommert K et al. (1997). Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3: 447-450.
5. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W et al. (2001). SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 98: 13681-13686.
6. Caruz A, Samsom M, Alonso JM, Alcami J, Baleux F, Virelizier JL et al. (1998). Genomic organization and promoter characterization of human CXCR4 gene. FEBS Lett 426: 271-278.
7. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF et al. (1995). SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 364: 229-233.
8. Darash-Yahana M, Pikarsky E, Abramovitch R, Zeira E, Pal B, Karplus R et al. (2004). Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 18: 1240-1242.
9. Dooley S, Said HM, Gressner AM, Floege J, En-Nia A, Mertens PR. (2006). Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J Biol Chem 281: 1784-1795.
10. Eisen MB, Spellman PT, Brown PO, Botstein D. (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868.
11. En-Nia A, Yilmaz E, Klinge U, Lovett DH, Stefanidis I, Mertens PR. (2005). Transcription factor YB-1 mediates DNA polymerase alpha gene expression. J Biol Chem 280: 702-711.
12. Evdokimova V, Ruzanov P, Imataka H, Raught B, Svitkin Y, Ovchinnikov LP et al. (2001). The major mRNA-associated protein YB-1 is a potent 5′ cap-dependent mRNA stabilizer. EMBO J 20: 5491-5502.
13. Fukuda T, Ashizuka M, Nakamura T, Shibahara K, Maeda K, Izumi H et al. (2004). Characterization of the 5′-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein. Nucleic Acids Res 32: 611-622.
14. Furukawa M, Uchiumi T, Nomoto M, Takano H, Morimoto RI, Naito S et al. (1998). The role of an inverted CCAAT element in transcriptional activation of the human DNA topoisomerase IIalpha gene by heat shock. J Biol Chem 273: 10550-10555.
15. Holm PS, Bergmann S, Jurchott K, Lage H, Brand K, Ladhoff A et al. (2002). YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter. J Biol Chem 277: 10427-10434.
16. Hu L, Zaloudek C, Mills GB, Gray J, Jaffe RB. (2000). In vivo and in vitro ovarian carcinoma growth inhibition by a phosphatidylinositol 3-kinase inhibitor (LY294002). Clin Cancer Res 6: 880-886.
17. Huang X, Ushijima K, Komai K, Takemoto Y, Motoshima S, Kamura T et al. (2004). Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer. Gynecol Oncol 93: 287-291.
18. Ise T, Nagatani G, Imamura T, Kato K, Takano H, Nomoto M et al. (1999). Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res 59: 342-346.
19. Jiang YP, Wu XH, Shi B, Wu WX, Yin GR. (2006). Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 103: 226-233.
20. Kamura T, Yahata H, Amada S, Ogawa S, Sonoda T, Kobayashi H et al. (1999). Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma? Cancer 85: 2450-2454.
21. Kaneko Y, Kitazato K, Basaki Y. (2004). Integrin-linked kinase regulates vascular morphogenesis induced by vascular endothelial growth factor. J Cell Sci 117: 407-415.
22. Kohno K, Izumi H, Uchiumi T, Ashizuka M, Kuwano M. (2003). The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25: 691-698.
23. Koike K, Uchiumi T, Ohga T, Toh S, Wada M, Kohno K et al. (1997). Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett 417: 390-394.
24. Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M et al. (2005). CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers. Cancer Res 65: 465-472.
25. Kuwano M, Oda Y, Izumi H, Yang SJ, Uchiumi T, Iwamoto Y et al. (2004). The role of nuclear Y-box binding protein 1 as a global marker in drug resistance. Mol Cancer Ther 3: 1485-1492.
26. Ladomery M, Sommerville J. (1995). A role for Y-box proteins in cell proliferation. Bioessays 17: 9-11.
27. Maruyama Y, Ono M, Kawahara A, Yokoyama T, Basaki Y, Kage M et al. (2006). Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res 66: 6233-6242.
28. Matsumoto K, Wolffe AP. (1998). Gene regulation by Y-box proteins: coupling control of transcription and translation. Trends Cell Biol 8: 318-323.
29. Mossink MH, van Zon A, Scheper RJ, Sonneveld P, Wiemer EA. (2003). Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 22: 7458-7467.
30. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME et al. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
31. Murakami T, Maki W, Cardones AR, Fang H, Tun Kyi A, Nestle FO et al. (2002). Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res 62: 7328-7334.
32. Ohga T, Koike K, Ono M, Makino Y, Itagaki Y, Tanimoto M et al. (1996). Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res 56: 4224-4228.
33. Ohga T, Uchiumi T, Makino Y, Koike K, Wada M, Kuwano M et al. (1998). Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J Biol Chem 273: 5997-6000.
34. Porcile C, Bajetto A, Barbieri F, Barbero S, Bonavia R, Biglieri M et al. (2005). Stromal cell-derived factor-1alpha (SDF-1alpha/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation. Exp Cell Res 308: 241-253.
35. Robledo MM, Bartolome RA, Longo N, Rodriguez-Frade JM, Mellado M, Longo I et al. (2001). Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J Biol Chem 276: 45098-45105.
36. Scotton CJ, Wilson JL, Milliken D, Stamp G, Balkwill FR. (2001). Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61: 4961-4965.
37. Scotton CJ, Wilson JL, Scott K, Stamp G, Wilbanks GD, Fricker S et al. (2002). Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. Cancer Res 62: 5930-5938.
38. Sorokin AV, Selyutina AA, Skabkin MA, Guryanov SG, Nazimov IV, Richard C et al. (2005). Proteasome-mediated cleavage of the Y-box-binding protein 1 is linked to DNA-damage stress response. EMBO J 24: 3602-3612.
39. Stein U, Bergmann S, Scheffer GL, Scheper RJ, Royer HD, Schlag PM et al. (2005). YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene. Oncogene 24: 3606-3618.
40. Stein U, Jurchott K, Walther W, Bergmann S, Schlag PM, Royer HD. (2001). Hyperthermia-induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J Biol Chem 276: 28562-28569.
41. Stenina OI, Poptic EJ, DiCorleto PE. (2000). Thrombin activates a Y box-binding protein (DNA-binding protein B) in endothelial cells. J Clin Invest 106: 579-587.
42. Sutherland BW, Kucab J, Wu J, Lee C, Cheang MC, Yorida E et al. (2005). Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene 24: 4281-4292.